You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nasal instillation

Showing 1 - 25 of 3,768
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cystic Fibrosis Trial in Brussels (Vardenafil, Placebo)

Terminated
  • Cystic Fibrosis
  • Brussels, Belgium
    Cliniques universitaires St. Luc
Feb 21, 2019

Practicality, Efficacy, and Ease of Lignocaine Nebulization Compared to Traditional Upper Airway Block for Awake Nasal

Completed
  • Practicality, Efficacy, and Ease of Lignocaine Nebulization Compared to Traditional Upper Airway Block for Awake Nasal Fiberoptic Intubation
  • Awake nasal fiberoptic intubation
  • Cairo, Egypt
    Sameh Refaat
Feb 1, 2023

Lung Transplant; Complications, Mechanical, Lung Transplant; Complications, Bleeding Trial in Baltimore (Topical epinephrine,

Completed
  • Lung Transplant; Complications, Mechanical
  • +3 more
  • Topical epinephrine
  • Placebos
  • Baltimore, Maryland
  • +1 more
Jan 21, 2023

Respiratory Distress Syndrome, Bronchopulmonary Dysplasia Trial in Roma (Ventilator for High-frequency Oscillatory Ventilation

Recruiting
  • Respiratory Distress Syndrome
  • Bronchopulmonary Dysplasia
  • Ventilator for High-frequency Oscillatory Ventilation (HFOV)
  • Less invasive surfactant administration (LISA)
  • Roma, Italy
    Fondazione Policlinico Agostino Gemelli IRCCS
Jan 25, 2023

Dry Eye Disease Trial in Louisville, Nashville (OC-02 (simpinicline) nasal spray, Placebo (vehicle) nasal spray)

Completed
Has Results
  • Dry Eye Disease
  • OC-02 (simpinicline) nasal spray
  • Placebo (vehicle) nasal spray
  • Louisville, Kentucky
  • +1 more
Feb 25, 2022

Respiratory Distress Syndrome, Newborn, Premature Birth Trial in Evanston (Poractant Alfa)

Not yet recruiting
  • Respiratory Distress Syndrome, Newborn
  • Premature Birth
  • Poractant Alfa
  • Evanston, Illinois
    Northshore University Healthsystem
Aug 22, 2023

Asthma, Allergic Trial (Anakinra, Preservative-free 0.9% sodium chloride (Placebo), House dust mite allergen)

Withdrawn
  • Asthma, Allergic
  • (no location specified)
Jun 7, 2022

Urinary Incontinence, Overactive Bladder With Urinary Incontinence Trial in Canada, United States (OnabotulinumtoxinA and

Completed
Has Results
  • Urinary Incontinence
  • Overactive Bladder With Urinary Incontinence
  • OnabotulinumtoxinA and Hydrogel admixture
  • Placebo and Hydrogel admixture
  • Birmingham, Alabama
  • +62 more
Jul 21, 2021

Analyzing Urine During BCG Instillation in Bladder Cancer

Not yet recruiting
  • Bladder Cancer
  • urine sample collection
  • Shanghai, Shanghai, China
    Changhai Hospital
Nov 30, 2023

Dry Eye Disease Trial in Louisville, Andover, Nashville (0.2 % hemigalactarate (0.11% free base) 0.2 % OC-02 Low Dose (1.1

Completed
Has Results
  • Dry Eye Disease
  • 0.2 % hemigalactarate (0.11% free base) 0.2 % OC-02 Low Dose (1.1 mg/mL)
  • +3 more
  • Louisville, Kentucky
  • +2 more
Nov 16, 2021

Long Term Follow up Dry Eye Disease Trial in Newport Beach, Indianapolis, Andover (OC-01 Low Dose, 0.12 mg/mL, OC-01 Mid Dose,

Completed
Has Results
  • Long Term Follow up Dry Eye Disease
  • OC-01 Low Dose, 0.12 mg/mL
  • +3 more
  • Newport Beach, California
  • +2 more
Oct 21, 2021

Dry Eye Disease Trial in Newport Beach, Indianapolis, Andover (OC-01 (varenicline) nasal spray, Placebo (vehicle) nasal spray)

Completed
Has Results
  • Dry Eye Disease
  • OC-01 (varenicline) nasal spray
  • Placebo (vehicle) nasal spray
  • Newport Beach, California
  • +2 more
Oct 21, 2021

Respiratory Distress Syndrome Trial in Evanston (MIST surfactant)

Not yet recruiting
  • Respiratory Distress Syndrome
  • MIST surfactant
  • Evanston, Illinois
    Northshore University Healthsystem
Sep 27, 2023

Myopia Trial (CP1, 0.01% atropine)

Not yet recruiting
  • Myopia
  • CP1
  • 0.01% atropine
  • (no location specified)
Sep 11, 2023

Dry Eye Disease (DED) Trial in United States (OC-01 (varenicline) nasal spray, Placebo (vehicle) nasal spray)

Completed
Has Results
  • Dry Eye Disease (DED)
  • OC-01 (varenicline) nasal spray
  • Placebo (vehicle) nasal spray
  • Phoenix, Arizona
  • +21 more
Oct 22, 2021

Cataract Surgery Trial in Roma (Efficacy of a Standardized Intracameral Combination of Mydriatics and Anesthetic (Mydrane ®) for

Completed
  • Cataract Surgery
  • Efficacy of a Standardized Intracameral Combination of Mydriatics and Anesthetic (Mydrane ®) for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma
  • Roma, Italy
    Policlinico Gemelli
Jul 4, 2023

Ischemic Attack, Transient, Transient Trial (Intransal instillation of E-selectin)

Withdrawn
  • Ischemic Attack, Transient
  • Transient
  • Intransal instillation of E-selectin
  • (no location specified)
Jul 3, 2018

Dry Eye Syndromes Trial in Osaka (OPC-12759 Ophthalmic solution, OPC-12759 Ophthalmic suspension)

Completed
Has Results
  • Dry Eye Syndromes
  • OPC-12759 Ophthalmic solution
  • OPC-12759 Ophthalmic suspension
  • Osaka, Japan
    Kansai region
Jun 3, 2021

Respiratory Distress Syndrome in Premature Infant Trial in Canada, United States (AeroFact, nCPAP)

Recruiting
  • Respiratory Distress Syndrome in Premature Infant
  • Little Rock, Arkansas
  • +38 more
Feb 22, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Homewood, Alabama
  • +4 more
Dec 15, 2022

Bronchiolitis Trial (Physiotheraphy + Conventional treatment, Conventional treatment)

Recruiting
  • Bronchiolitis
  • Physiotheraphy + Conventional treatment
  • Conventional treatment
  • Porto, Portugal
    Faculdade de Desporto da Universidade do Porto
Sep 28, 2022

Laparoscopic, Ultrasound, Transversus Abdominis Plane Block Trial in Tanta (Ultrasound-guided transversus abdominis plane block,

Recruiting
  • Laparoscopic
  • +5 more
  • Ultrasound-guided transversus abdominis plane block
  • +3 more
  • Tanta, El-Gharbia, Egypt
    Tanta University
Oct 24, 2023

Infant, Extremely Premature, Acute Lung Injury, Chronic Lung Disease of Prematurity Trial in Tucson (Infants in the study group

Recruiting
  • Infant, Extremely Premature
  • +3 more
  • Infants in the study group (S/B group) will receive surfactant 2.5 mls/kg and Budesonide 0.5 mg (1mL)
  • Infants in the control group (S/P group) receive placebo (Normal saline 1mL)
  • Tucson, Arizona
    University of Arizona
Oct 31, 2022

Dry Eye Trial in Baltimore (Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug)

Recruiting
  • Dry Eye
  • Sustained Release Dexamethasone, 0.4 mg
  • E-Caprolactone-L-Lactide copolymer (PCL) punctal plug
  • Baltimore, Maryland
    Wilmer Eye Institute, Johns Hopkins School of Medicine
Jan 24, 2022

Dry Eye Trial in United States (0.25% HL036 Ophthalmic Solution, Placebo)

Completed
  • Dry Eye
  • 0.25% HL036 Ophthalmic Solution
  • Placebo
  • Phoenix, Arizona
  • +9 more
Jan 4, 2023